Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-88
Closed -$4K 2575
2018
Q1
$4K Hold
88
﹤0.01% 2495
2017
Q4
$4K Hold
88
﹤0.01% 2495
2017
Q3
$3K Sell
88
-5,603
-98% -$266K ﹤0.01% 2537
2017
Q2
$275K Hold
5,691
﹤0.01% 1109
2017
Q1
$275K Sell
5,691
-212
-4% -$10.5K ﹤0.01% 1109
2016
Q4
$310K Sell
5,903
-350
-6% -$18K ﹤0.01% 1080
2016
Q3
$322K Buy
6,253
+100
+2% +$5.01K ﹤0.01% 1055
2016
Q2
$289K Hold
6,153
﹤0.01% 1082
2016
Q1
$278K Buy
6,153
+5,317
+636% +$236K ﹤0.01% 1073
2015
Q4
$46K Buy
836
+536
+179% +$27.1K ﹤0.01% 1597
2015
Q3
$13K Hold
300
﹤0.01% 2048
2015
Q2
$15K Hold
300
﹤0.01% 2005
2015
Q1
$19K Hold
300
﹤0.01% 1967
2014
Q4
$17K Sell
300
-450
-60% -$24.2K ﹤0.01% 2071
2014
Q3
$38K Sell
750
-165
-18% -$7.75K ﹤0.01% 1783
2014
Q2
$40K Sell
915
-435
-32% -$18.1K ﹤0.01% 1695
2014
Q1
$52K Hold
1,350
﹤0.01% 1637
2013
Q4
$54K Buy
1,350
+200
+17% +$7.39K ﹤0.01% 1601
2013
Q3
$48K Hold
1,150
﹤0.01% 1609
2013
Q2
$54K Buy
+1,150
New +$52.1K ﹤0.01% 1506

Other funds holding ABAX

Glenmede Trust's ABAX Position: Q2 2018 in Review

Glenmede Trust sold out of Abaxis Inc (ABAX) in Q2 2018, closing a stake of 88 shares — an estimated $4K sold.

Glenmede Trust first reported a position in ABAX in Q2 2013 and held it in 20 quarters. The position peaked at $322K in Q3 2016. 168 funds tracked by Wall St. Rank hold ABAX as of Q2 2018.

  • Glenmede Trust reported no remaining Abaxis Inc position as of Q2 2018 after selling out during the quarter.
  • Glenmede Trust sold 88 Abaxis Inc shares in Q2 2018, an estimated $4K.
  • Glenmede Trust first reported a position in Abaxis Inc in Q2 2013 and held it in 20 quarters.
  • Glenmede Trust's Abaxis Inc position peaked at $322K in Q3 2016.
  • 168 funds tracked by Wall St. Rank held Abaxis Inc as of Q2 2018.

Based on Glenmede Trust's 13F filing for Q2 2018, filed 15 Aug 2018.